We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The 2009 PPRS is a five-year voluntary scheme effective from 1 January 2009, agreed between Government and the pharmaceutical industry.
This brief presents some trends and developments of the Kenyan pharmaceutical industry
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
The CMU is part of the Medicine, Pharmacy and Industry Group of DHSC which looks at supply and procurement in hospitals.
Directions given by the Secretary of State for Health under powers conferred by statute.
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
Pharmaceutical production has been a Tanzanian industrial success, generating skills and employment and access to essential medicines
The 12th report updates parliament on the Pharmaceutical Price Regulation Scheme (PPRS).
How to manage trade taxation policy in such a way that public revenue can be acquired but not at the cost of long term industrialisation
Pharmaceutical Assessor vacancy, working in the regulation of veterinary pharmaceutical medicines.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Findings from the review of regulatory enforcement in the pharmaceutical sector.
This publication supports local authority health and wellbeing boards to develop and update pharmaceutical needs assessments (PNAs).
The Ministerial Industry Strategy Group (MISG) brings together government and the bio-pharmaceutical industry. The purpose of the group is to jointly consider how to promote a strong and profitable UK-based bio-pharmaceutical industry. The group is co-chaired by the Secretary of...
Third Pharmaceuticals in the Environment (PiE) Group meeting continue discussions regarding imidacloprid and fipronil.
British Pharmacopoeia (BP) provides official standards for pharmaceutical substances and medicinal products. British Pharmacopoeia Commission is an advisory non-departmental public body, sponsored by the Department of Health and Social Care .
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.